<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lin LL</submitter><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of General Medical Sciences</funding><funding>U.S. Department of Health &amp; Human Services | NIH | National Institute of General Medical Sciences (NIGMS)</funding><funding>U.S. Department of Health &amp; Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes &amp; Digestive &amp; Kidney Diseases)</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases</funding><pagination>2064</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12949252</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(1)</volume><pubmed_abstract>The SEL1L-HRD1 complex represents the most conserved branch of endoplasmic reticulum (ER)-associated degradation (ERAD), a critical quality-control pathway that clears misfolded ER proteins. However, the molecular organization and pathogenic mechanisms of mammalian ERAD have remained elusive. Here, we report the cryo-EM structure of the core mammalian ERAD complex, comprising the ER lectin OS9, SEL1L, and the E3 ubiquitin ligase HRD1. The structure, validated by mutagenesis and crosslinking assays, reveals a dimeric assembly of the core complex in which SEL1L and OS9 form a claw-like configuration in the ER lumen that mediates substrate engagement, while HRD1 dimerizes within the membrane that may facilitate substrate translocation. Furthermore, pathogenic SEL1L mutations at the SEL1L-OS9 </pubmed_abstract><journal>Nature communications</journal><pubmed_title>Structural basis and pathological implications of the dimeric OS9-SEL1L-HRD1 ERAD Core Complex.</pubmed_title><pmcid>PMC12949252</pmcid><funding_grant_id>R35GM130292</funding_grant_id><funding_grant_id>R01DK120047</funding_grant_id><funding_grant_id>R01DK120330</funding_grant_id><pubmed_authors>Qi L</pubmed_authors><pubmed_authors>Lin LL</pubmed_authors><pubmed_authors>Maldosevic E</pubmed_authors><pubmed_authors>Jomaa A</pubmed_authors><pubmed_authors>Zhou LE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Structural basis and pathological implications of the dimeric OS9-SEL1L-HRD1 ERAD Core Complex.</name><description>The SEL1L-HRD1 complex represents the most conserved branch of endoplasmic reticulum (ER)-associated degradation (ERAD), a critical quality-control pathway that clears misfolded ER proteins. However, the molecular organization and pathogenic mechanisms of mammalian ERAD have remained elusive. Here, we report the cryo-EM structure of the core mammalian ERAD complex, comprising the ER lectin OS9, SEL1L, and the E3 ubiquitin ligase HRD1. The structure, validated by mutagenesis and crosslinking assays, reveals a dimeric assembly of the core complex in which SEL1L and OS9 form a claw-like configuration in the ER lumen that mediates substrate engagement, while HRD1 dimerizes within the membrane that may facilitate substrate translocation. Furthermore, pathogenic SEL1L mutations at the SEL1L-OS9 </description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-07-16T23:28:30.311Z</modification><creation>2026-07-12T03:11:14.607Z</creation></dates><accession>S-EPMC12949252</accession><cross_references><pubmed>41593065</pubmed><doi>10.1038/s41467-026-68777-7</doi></cross_references></HashMap>